Page last updated: 2024-09-04

cinacalcet and Bone Loss, Osteoclastic

cinacalcet has been researched along with Bone Loss, Osteoclastic in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's10 (83.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Chang, JF; Chiu, IJ; Hsieh, CY; Hsu, YH; Hung, KC; Hung, LY; Lu, KC; Syu, RS; Wang, TM; Wu, CC; Wu, MS; Wu, MY; Zheng, CM1
Chang, TJ; Chiu, HW; Hsu, YH; Lin, YF; Liu, WC; Lu, CL; Lu, KC; Shyu, JF; Wu, CC; Zheng, CM; Zheng, JQ1
Barros, X; Torregrosa, JV1
Behets, GJ; D'Haese, PC; De Broe, ME; Goodman, WG; Spasovski, G; Spiegel, DM; Sterling, LR1
Hasegawa, E; Hayami, N; Hiramatsu, R; Hoshino, J; Imafuku, A; Kawada, M; Mise, K; Sawa, N; Sumida, K; Suwabe, T; Takaichi, K; Ubara, Y1
Inaba, M1
Akizawa, T; Iwasaki, M; Koshikawa, S; Shigematsu, T; Tsukamoto, Y; Uchida, E1
Himeno, Y; Shigeno, K; Sugimoto, T; Sumi, M; Suzuki, K; Tokumoto, A; Yano, S1
Finch, JL; Lane, N; Nakamura, H; Shahnazari, M; Slatopolsky, E; Tokumoto, M; Yao, W1
Goltzman, D1
Bajo-Rubio, MA; De Sousa-Amorim, E; Del Peso-Gilsanz, G; Selgas-GutiƩrrez, R1
Eriguchi, M; Haruyama, N; Kitazono, T; Nakano, T; Tanaka, S; Taniguchi, M; Tsuruya, K; Yamada, S; Yoshida, H1

Reviews

1 review(s) available for cinacalcet and Bone Loss, Osteoclastic

ArticleYear
Management of hypercalcemia after renal transplantation.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Nov-13, Volume: 33, Issue:6

    Topics: Algorithms; Bone Resorption; Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Postoperative Complications; Renal Dialysis; Vitamin D

2013

Trials

3 trial(s) available for cinacalcet and Bone Loss, Osteoclastic

ArticleYear
Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism.
    Kidney international, 2015, Volume: 87, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Diseases, Metabolic; Bone Resorption; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Osteogenesis; Parathyroid Hormone; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Young Adult

2015
Denosumab for low bone mass in hemodialysis patients: a noncontrolled trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015, Volume: 66, Issue:1

    Topics: Aged; Antibodies, Monoclonal, Humanized; Biomarkers; Bone Density Conservation Agents; Bone Resorption; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Contraindications; Denosumab; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Osteoclasts; Prospective Studies; RANK Ligand; Renal Dialysis

2015
Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism.
    American journal of nephrology, 2009, Volume: 29, Issue:3

    Topics: Adult; Aged; Bone and Bones; Bone Resorption; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Renal Dialysis; Treatment Outcome

2009

Other Studies

8 other study(ies) available for cinacalcet and Bone Loss, Osteoclastic

ArticleYear
Therapeutic Effect of Calcimimetics on Osteoclast-Osteoblast Crosslink in Chronic Kidney Disease and Mineral Bone Disease.
    International journal of molecular sciences, 2020, Nov-18, Volume: 21, Issue:22

    Topics: Adult; Aged; Biomarkers; Bone Density; Bone Diseases; Bone Resorption; Calcimimetic Agents; Cinacalcet; Female; Humans; Male; Middle Aged; Osteoblasts; Osteoclasts; Osteogenesis; Outcome Assessment, Health Care; Parathyroid Hormone; Renal Dialysis; Renal Insufficiency, Chronic; Tartrate-Resistant Acid Phosphatase

2020
Osteoclast-Released Wnt-10b Underlies Cinacalcet Related Bone Improvement in Chronic Kidney Disease.
    International journal of molecular sciences, 2019, Jun-08, Volume: 20, Issue:11

    Topics: Animals; Bone Density; Bone Resorption; Calcium-Regulating Hormones and Agents; Cells, Cultured; Cinacalcet; Male; Mice; Mice, Inbred C57BL; Osteoclasts; Renal Insufficiency, Chronic; Wnt Proteins

2019
Importance of abnormal bone metabolism in the acceleration of atherosclerosis in hemodialysis patients.
    Contributions to nephrology, 2015, Volume: 185

    Topics: Atherosclerosis; Bone Resorption; Calcimimetic Agents; Calcium; Cinacalcet; Disease Progression; Humans; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Vascular Calcification

2015
Bone metabolism after cinacalcet administration in patients with secondary hyperparathyroidism.
    Journal of bone and mineral metabolism, 2010, Volume: 28, Issue:1

    Topics: Acid Phosphatase; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Regeneration; Bone Remodeling; Bone Resorption; Calcium; Cinacalcet; Drug Administration Schedule; Female; Hormone Antagonists; Humans; Hyperparathyroidism, Secondary; Isoenzymes; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Tartrate-Resistant Acid Phosphatase; Time Factors

2010
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
    American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:6

    Topics: Animals; Biomarkers; Bone Resorption; Calcitriol; Calcium; Cinacalcet; Creatinine; Disease Models, Animal; Ergocalciferols; Female; Fibroblast Growth Factors; Hyperparathyroidism; Hyperphosphatemia; Hypocalcemia; Naphthalenes; Nephrectomy; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; Severity of Illness Index; Tibia; Uremia

2010
Do calcimimetics directly alter bone remodeling?
    American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:6

    Topics: Animals; Biomarkers; Bone Remodeling; Bone Resorption; Calcitriol; Cinacalcet; Ergocalciferols; Fibroblast Growth Factors; Humans; Hyperparathyroidism; Hyperphosphatemia; Hypocalcemia; Naphthalenes; Parathyroid Hormone; Rats; Renal Insufficiency, Chronic; Severity of Illness Index; Tibia; Treatment Outcome; Uremia

2010
Asymptomatic polyostotic Paget's disease associated with secondary hyperparathyroidism in a peritoneal dialysis patient.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2012, Jul-17, Volume: 32, Issue:4

    Topics: Aged; Alkaline Phosphatase; Arthritis, Gouty; Asymptomatic Diseases; Bone Resorption; Calcifediol; Cinacalcet; Contraindications; Diphosphonates; Humans; Hyperparathyroidism, Secondary; Hypertension; Kidney Failure, Chronic; Male; Naphthalenes; Osteitis Deformans; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Radionuclide Imaging

2012
The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Clinical endocrinology, 2013, Volume: 78, Issue:6

    Topics: Acid Phosphatase; Acute Kidney Injury; Adult; Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Resorption; Cinacalcet; Collagen Type I; Cross-Sectional Studies; Female; Humans; Hydroxycholecalciferols; Isoenzymes; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Peptides; Peritoneal Dialysis; Raloxifene Hydrochloride; Regression Analysis; Tartrate-Resistant Acid Phosphatase

2013